Last updated 21/01/21
ARMA is working to support our members to share information and respond effectively to the coronavirus outbreak. Patient organisations are working to ensure people have the advice they need related to their condition or medication. Our professional members are working to ensure healthcare professionals have access to the information they need about the virus and also how to continue to provide healthcare support in the current situation.
ARMA is signposting the most relevant information we can find and will update this page as new information becomes available. It includes information for professionals, patients, parents and guidance for Wales and Scotland.
Latest advice for England.
Good communication with patients whose planned care has been disrupted by COVID-19.
Information on vaccination
Principles for COVID-19 Vaccination in Musculoskeletal and Rheumatology for Clinicians
NHS information for the public on vaccination:
BSR information on vaccination:
General Chiropractic Council statement on the vaccine:
Information for people with MSK conditions
National Rheumatoid Arthritis Society
Scleroderma & Raynaud’s UK
NHS response to COVID-19
Operational priorities for winter and 2021/22 (Letter dated 23/12/20)
NHSE Speciality guides including:
Most specialty guides for MSK are no longer published on the NHSE website.
Management of rheumatology patients during the coronavirus pandemic and management of urgent and emergency spinal surgical patients are now on the NICE website.
Clinical Validation of Surgical Waiting Lists: framework and support tools
NICE Covid-19 rapid guidance: arranging planned care in hospitals and diagnostic services (26/7/20)
Re-starting non-urgent trauma and orthopaedic care guidance from British Orthopaedic Association
NICE COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders.
Management of patients with musculoskeletal and rheumatic conditions who: are on corticosteroids; require initiation of oral/IV corticosteroids; require a corticosteroid injection (20/11/20)
- Denosumab (Prolia) treatment and the COVID-19 pandemic
- Toolkit: DXA restoration of service
- Guidance: Secondary fracture prevention for inpatients during COVID-19 pandemic
- All on the Royal Osteoporosis Society Covid-19 Hub
There is different advice for those people considered Clinically Extremely Vulnerable (previously shielding).
Guidance letters have been sent to GPs and Acute Trusts updating on the guidance and identifying actions. (2/11/20)
Identifying high risk patients who should be shielding – The information in relation to rheumatology is on the BSR website.
COVID-19 – ‘shielding’ guidance for children and young people:
Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19 (updated 7 January):
Community MSK services
Restoration of community health services
The Stanford Hall consensus statement for post-COVID-19 rehabilitation
Guidance from the CSP on implementing remote consultations
COVID-19 – talking to children and families about returning to school: guiding principles
Information about NICE rapid guidelines on the active management of COVID-19 infection. NICE are also reviewing guidance on ibuprofen and other non-steroidal anti-inflammatory drugs in relation to impact on covid-19 illness.
Guidance on infection prevention and control for COVID-19
Guidance on Vitamin D supplements for people getting out less due to shielding, isolating or lockdown.
A risk calculator for rheumatology patients to assess their risk and whether you should be isolating or shielding.
FAQs for patients on resuming surgical services
Many patient organisations have helplines and web-based information.
Arthritis Action: https://www.arthritisaction.org.uk/covid-19-advice/
Fibromyalgia UK: http://www.fmauk.org/coronavirus
Hypermobility Syndromes Association: https://www.hypermobility.org/news/covid19-resources
Lupus UK: https://www.lupusuk.org.uk/coronavirus/
National Axial Spondyloarthritis Society (NASS): https://nass.co.uk/managing-my-as/covid19-coronavirus/
National Rheumatoid Arthritis Society (NRAS): https://www.nras.org.uk/coronavirus (info page);
and Here For You, a new service that allows you to arrange a callback with someone with RA who understands you: https://www.nras.org.uk/here-for-you
Psoriasis Association: https://www.psoriasis-association.org.uk/psoriasis-and-treatments/covid-19-information
Royal Osteoporosis Society: https://theros.org.uk/information-and-support/coronavirus-and-osteoporosis
Scleroderma & Raynaud’s UK (SRUK): https://www.sruk.co.uk/about-us/news/novel-coronavirus-covid-19-advice-our-community/
From SPARN (Scottish Paediatric and Adolescent Rheumatology Network)
CCCA Kids with Arthritis incorporating JIA Matters facebook group
Great Ormond Street Hospital advice for parents of vulnerable children and young people – useful practical advice on shielding for a child.
Resources for young people – specifically about shielding and social distancing and developed with input of children/young people.
Guidance for professionals (nothing MSK specific)
COVID-19 High risk shielded patient list identification methodology (note different methodology for rheumatology from England and guidance below contains more up to date list)
Guidance on shielding and protecting people defined on medical grounds as extremely vulnerable from coronavirus (COVID-19). (updated 23 October).
https://gov.wales/get-coronavirus-support-extremely-vulnerable-person – contact your local authority
Guidance for healthcare professionals
Shielding advice (updated 8 October)
Information for Northern Ireland